Healthcare >> CEO Interviews >> May 29, 2000

Jeffrey Jonas – Avax Technologies Inc (avxt)

DR. JEFFREY M. JONAS, MD, is President and Chief Executive Officer of AVAX Technology, Inc. and has extensive experience in pharmaceutical development, including the areas of biotechnology, pharmacoeconomics, and psychopharmacology, as well as the acquisition and development of new cancer, antibiotic and immunological drugs. From 1994 to 1996, Dr. Jonas was Vice President of Clinical Development and Chief Medical Officer of Upjohn Laboratories. From 1991 to 1996, Dr. Jonas held positions at the Upjohn Company as Vice President of Worldwide Pharmaceutical Regulatory Affairs, Director of Psychopharmacology and Vice President of Clinical Development. Dr. Jonas is the author of a book on Prozac_ and over 100 scientific articles, abstracts, and book chapters. Dr. Jonas received his MD from Harvard Medical School in 1979 and a BA in Biology and English from Amherst College in 1975. Profile
TWST: Could we start out with a history and brief overview of AVAX, just

to set the stage for readers?

Dr. Jonas: AVAX is a biotechnology company that was founded in 1996. Our

primary research